HIV Prevention
Px Wire: Quarterly update on HIV prevention research, Vol 4, No 2
This is the latest issue of Px Wire, AVAC’s quarterly update on HIV prevention research—a one-stop source for information on biomedical HIV prevention research worldwide.
Highlights in this issue include a new look for the centerspread, which this quarter includes a trials table of ARV-based prevention research in HIV-positive people. We chart the decision-making around 1% tenofovir gel since the CAPRISA 004 trial yielded proof-of-concept nearly nine months ago. This issue also includes an update on the long-term protective benefit of medical male circumcision and encouraging news from follow-up research on the vaccine used in the Step trial. We bring you updates on the Good Participatory Practice Guidelines, including information on the launch of the second edition and a story of GPP in action.
Attached resource:
